Molecular Imaging

Gadopiclenol at half GBCA dose effective for pediatric brain MRI

By Kate Madden Yee

The findings are good news, in that children's exposure to gadolinium-based contrast agents (GBCAs) could be lowered.

June 25, 2025

SNMMI: Consider radiation safety when switching to F-18 MPI

By Amerigo Allegretto

Several safety considerations should be taken when adding F-18 myocardial perfusion imaging (MPI) to radiation oncology departments.

June 25, 2025

Prostate Cancer Foundation, SNMMI partner on prostate cancer research grant

By AuntMinnie.com staff writers

The Prostate Cancer Foundation (PCF) and the SNMMI are collaborating on a grant under the PCF 2025 Young Investigator Award program.

June 25, 2025

SNMMI: For PET drugs, sterility assurance bests sterility testing

By Liz Carey

Sterility testing is limited when it comes to detecting microbial contamination in PET drugs.

June 25, 2025

SNMMI: Jacene named president-elect

The SNMMI has named Heather Jacene, MD, as its president-elect.

June 24, 2025

SNMMI names Ulaner as vice president-elect

By AuntMinnie.com staff writers

Gary Ulaner, MD, PhD, has been named vice president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

June 24, 2025

Urbain takes helm as SNMMI president

By AuntMinnie.com staff writers

Jean-Luc Urbain, MD, PhD, has been named president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

June 24, 2025

FDA approves expanded uses for GE Healthcare’s Vizamyl

By AuntMinnie.com staff writers

The U.S. FDA has approved expanded indications for GE HealthCare’s Vizamyl PET imaging agent for beta-amyloid detection.

June 24, 2025

SNMMI: Botox may prevent debilitating dry mouth for some mCRPC patients

By Liz Carey

Research presented at the meeting addressed salivary gland toxicity associated with uptake of PSMA-targeted radioligand therapy.

June 24, 2025

Nuclidium presents phase I results for PSMA tracer at SNMMI

By AuntMinnie.com staff writers

Nuclidium presented positive data from the phase I clinical trial of its new copper-61 PET imaging agent for prostate cancer.

June 24, 2025

SNMMI: New PET imaging technique detects mycobacteria lung infections

By Kate Madden Yee

These infections are some of the most difficult-to-diagnose in patients with chronic lung diseases.

June 24, 2025

SNMMI: PET tracer images brain inflammation

By Amerigo Allegretto

A PET radiotracer can produce high-quality, real-time images of brain inflammation, which may help with diagnosing and treating neurological diseases.

June 24, 2025

Page 1 of 609

Next Page